Advertisement

Topics

Goldshield Group plc Company Profile

01:17 EST 24th February 2018 | BioPortfolio

The first pharmaceutical product was acquired from Glaxo in 1992 and there have been subsequent product acquisitions from SmithKline Beecham, Medeva, Warner Lambert and American Home Products. Between 1991 and 1993, the Group raised equity finance of £1.0 million from individual investors, many of whom are doctors, pharmacists, or from within the pharmaceutical industry. The Group became profitable in the year ended 31 March 1993.

Location

NLA Tower 12-16 Addiscombe Road
Croydon
Surrey
CR0 0XT
United Kingdom

Contact

Phone: 44 (0) 208 649 8500
Fax: 44 (0) 208 686 0807
Email: info@goldshieldplc.com


News Articles [313 Associated News Articles listed on BioPortfolio]

Huobi Group and SBI Group reached a strategic partnership agreement to jointly develop Global ...

Huobi Group was founded in 2013. After four years of steady operation, the Group has become a leading global digital asset financial service provider in Read more...

TMX Group Limited Declares Dividend of $0.50 per Common Share

For the results of the quarter ended December 31, 2017for TMX Group, please click on the following link: http://www.tmx.com/investor-relations/ About TMX Group (TSX:X) TMX Read more...

Maricann Group Inc.: Maricann Group expandiert in -2-

DJ Maricann Group Inc.: Maricann Group expandiert in den Spirituosenmarkt - genau wie Canopy Growth! Dow Jones hat von EQS/DGAP eine Zahlung für die Verbreitung dieser Pressemitteilung über sein N.....

Maricann Group Inc.: Maricann Group - Lizenz zur -2-

DJ Maricann Group Inc.: Maricann Group - Lizenz zur Produktion von Cannabis Kapseln! - Übernahmeangebote bei Konkurrenten! Dow Jones hat von EQS/DGAP eine Zahlung für die Verbreitung dieser Presse.....

Maricann Group Inc.: Maricann Group - Effizienz -2-

DJ Maricann Group Inc.: Maricann Group - Effizienz durch Automatisierung um bis zu 75 % erhöht! Dow Jones hat von EQS/DGAP eine Zahlung für die Verbreitung dieser Pressemitteilung über sein Netzwe....

CRP Group Is Ready to Amaze 2018 CES Attendees With Their Innovative Technology

MODENA, Italy, Dec. 28, 2017/PRNewswire/ -- CRP Group along with U.S.-based partner CRP USAand Energica - the sustainable subsidiary of CRP Group Read more...

Predictive Technology Group to Acquire FlagshipHealth Group

Predictive Technology Group, Inc., a provider of data analytics for disease identification and subsequent therapeutic intervention through unique biotechnology treatments has finalized an arrangement ...

In the blink of an eye: People perceive sex ratio and threat of group in less than a second

New research shows people perceive the sex ratio of a group, and decide if the group is threatening or not, in half a second. The perceptions of the number of men in the group are accurate, according ...

PubMed Articles [1808 Associated PubMed Articles listed on BioPortfolio]

Transcanalicular laser-assisted dacryocystorhinostomy with diode laser.

This article compares the efficacy of transcanalicular laser assisted dacryocystorhinostomy (TL DCR) with conventional external dacryocystorhinostomy (Ex DCR). All patients were randomly divided into ...

Thirty first annual symposium on etiology, pathogenesis, and treatment of Parkinson disease and other movement disorders: Presented by the Parkinson study group, huntington study group, dystonia study group, tourette syndrome study group, cooperative ataxia group, and tremor research group.

Medulloblastoma with transitional features between Group 3 and Group 4 is associated with good prognosis.

Medulloblastoma, the most common malignant pediatric brain tumor, is a heterogeneous disease, with the existence of at least four molecular types: Wingless (WNT), Sonic Hedgehog (SHH), Group 3 and Gro...

Application of the Pentafluorosulfanyl Group as a Bioisosteric Replacement.

The success of fluorinated molecules in drug design has led medicinal chemists to search for new fluorine-containing substituents. A major recently developed group is the pentafluorosulfanyl group. Th...

Systemic granulomatous disease in dairy cattle during a dicyandiamide feeding trial.

Mature, in-calf, non-lactating, Friesian or Friesian-cross cows were fed dicyandiamide (DCD) at daily doses of 0.15 g/kg (Group 1; n=31), 0.45 g/kg (Group 2; n=21) and 0.75 g/kg (Group 3; n=12), as pa...

Clinical Trials [3455 Associated Clinical Trials listed on BioPortfolio]

Safety, Tolerability and Pharmacokinetics of Escalating Single Doses of TAK-828 in Healthy Participants

The purpose of this study is to evaluate the safety and tolerability of single oral doses of TAK-828 in healthy non-Japanese and Japanese participants.

Technical Development of Multi-Parametric Renocerebral MRI

The purpose of the study is to investigate the associations of the age-related changes in the brain, kidneys and cognitive performance in healthy adults by utilizing multiple anatomic and ...

Electro-acupuncture and Flumazenil's Effect on Sedation

Object: To explore the mechanism of the electro-acupuncture (EA) induced sedation effect in general anaesthesia through investigating the role of the Benzodiazepines-GABA system. Method: ...

The Effect of Rhubarb on Sepsis and Post-traumatic Gastrointestinal Function Failure

Random grouping by computer, divided into two groups, a group of rhubarb treatment group, another group for the placebo group.

Does Cognitive Rehabilitation Demonstrate Benefits in the Group Setting With People Whom Have Experienced Brain Injury?

The purpose of this study is to determine whether there is benefit from providing cognitive rehabilitation in the group setting. Several standardized tools will be used to measure progres...

Companies [1595 Associated Companies listed on BioPortfolio]

Goldshield Group

Goldshield Group plc

The first pharmaceutical product was acquired from Glaxo in 1992 and there have been subsequent product acquisitions from SmithKline Beecham, Medeva, Warner Lambert and American Home Products. Between...

W2 Group, Inc.

W2 Group is a global marketing services ecosystem that helps CMOs in their new role as builders of communities and content aggregators. W2 Group companies, including Digital ...

PharmEvo (Pvt.) Ltd.

PharmEvo is backed by a reputable corporate group with a history of successful business ventures spread over 30 years. The group made its debut in 1971, with the sales and marketing of prestigious bra...

ACE Group

Celebrating 25 years of insuring progress, the ACE Group is a global leader in insurance and reinsurance serving a diverse group of clients. Headed by ACE Limited (NYSE:ACE), a co...

More Information about "Goldshield Group plc" on BioPortfolio

We have published hundreds of Goldshield Group plc news stories on BioPortfolio along with dozens of Goldshield Group plc Clinical Trials and PubMed Articles about Goldshield Group plc for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Goldshield Group plc Companies in our database. You can also find out about relevant Goldshield Group plc Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks



Searches Linking to this Company Record